Oncosil Medical Limited (ASX:OSL)
Share Pricing & News Healthcare

AUD 0.045

0 (0%)
(As on 2022-12-08 20:57:01 AEDT)
Previous Close Open Close*
0.045 0.046 0.045
Market Cap Dividend Yield (Annualized)
AUD 44.741M 0.00%

Day Range
0.045L 0.046 H
52 WEEK HIGH LOW
0.0326L 0.0800181818 H

Chart Price & Information

Last Trade 0.045
Change% 0.0000
52 W H/L 0.080/0.033
EBITDA -11.409M
NPAT After Abnormal Items -10.727M
Equity 11.163M
ROE% -96.09%
Total Liabilities 1.907M
Total Revenue 923,899
Cash and Cash Equivalents 11.28M

Stock Information

Share price 0.045
Market Cap 44.741M
Price/Gross Cash Flow -5.38
Dividend Yield Excluding Special 0.00%
Ending Shares 991.242M
52-Week Range 0.080-0.033
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.01
P/E ratio 0.000
Sector P/E --
EPS -1.32
EV/EBITDA --
Net Profit Margin (%) -4,627.79%
Gross Cash Flows Per Share -0.01
Net Gearing -98.32%
Sales Per Share 0.00
Book Value Per Share 0.01

Similar Companies

Related Articles

About Company

Oncosil Medical Limited (ASX: OSL) is under health care sector which is into the Oncology Research and Development. It is a device-based company focused on treatments for patients with cancer and is also engaged into the development of lead product candidate, the Oncosil localized radiation therapy. With regards to commercialization, the company has been focusing on an application Conformite Europeene mark for European Union. The company was incorporated in 2005.

Corporate Information


Suite 402 Level 4, 50 Berry Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060

Phone:(02) 9223 3344

Website:http://www.oncosil.com.au

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2023-08-30 2023
Report (Prelim) 2023-08-30 2023
Report (Interim) 2023-02-21 2023